NPPB and hydrops fetalis: In order to evaluate the performance of serum sAXL as a valuable HF biomarker in each group of patients, we analyzed the predictive value of NT-proBNP dividing the cohorts in quartiles and compared the result with the performance of sAXL (Figure 2).